178 related articles for article (PubMed ID: 20581056)
1. HIV-associated nephropathy: role of mammalian target of rapamycin pathway.
Kumar D; Konkimalla S; Yadav A; Sataranatarajan K; Kasinath BS; Chander PN; Singhal PC
Am J Pathol; 2010 Aug; 177(2):813-21. PubMed ID: 20581056
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 promotes renal tubular epithelial cell protein synthesis: role of mTOR pathway.
Rehman S; Husain M; Yadav A; Kasinath BS; Malhotra A; Singhal PC
PLoS One; 2012; 7(1):e30071. PubMed ID: 22253885
[TBL] [Abstract][Full Text] [Related]
3. Renin angiotensin system modulates mTOR pathway through AT2R in HIVAN.
Rai P; Lederman R; Haque S; Rehman S; Kumar V; Sataranatrajan K; Malhotra A; Kasinath BS; Singhal PC
Exp Mol Pathol; 2014 Jun; 96(3):431-7. PubMed ID: 24768585
[TBL] [Abstract][Full Text] [Related]
4. mTOR plays a critical role in p53-induced oxidative kidney cell injury in HIVAN.
Rai P; Plagov A; Lan X; Chandel N; Singh T; Lederman R; Ayasolla KR; Mathieson PW; Saleem MA; Husain M; Malhotra A; Chander PN; Singhal PC
Am J Physiol Renal Physiol; 2013 Aug; 305(3):F343-54. PubMed ID: 23678040
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of the activated mammalian target of rapamycin pathway might be associated with renal function reserve by a low-protein diet in the rat remnant kidney model.
Ohkawa S; Yanagida M; Uchikawa T; Yoshida T; Ikegaya N; Kumagai H
Nutr Res; 2013 Sep; 33(9):761-71. PubMed ID: 24034576
[TBL] [Abstract][Full Text] [Related]
6. Tubular cell phenotype in HIV-associated nephropathy: role of phospholipid lysophosphatidic acid.
Ayasolla KR; Rai P; Rahimipour S; Hussain M; Malhotra A; Singhal PC
Exp Mol Pathol; 2015 Aug; 99(1):109-15. PubMed ID: 26079546
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus modulates HIVAN phenotype through inhibition of epithelial mesenchymal transition.
Yadav A; Kumar D; Salhan D; Rattanavich R; Maheshwari S; Adabala M; Ding G; Singhal PC
Exp Mol Pathol; 2012 Aug; 93(1):173-81. PubMed ID: 22579465
[TBL] [Abstract][Full Text] [Related]
8. Involvement of mTOR and Regulation by AMPK in Early Iodine Deficiency-Induced Thyroid Microvascular Activation.
Craps J; Joris V; De Jongh B; Sonveaux P; Horman S; Lengelé B; Bertrand L; Many MC; Colin IM; Gérard AC
Endocrinology; 2016 Jun; 157(6):2545-59. PubMed ID: 27035650
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
Liu NN; Zhao N; Cai N
IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
[TBL] [Abstract][Full Text] [Related]
10. Curcumin Ameliorates Chronic Renal Failure in 5/6 Nephrectomized Rats by Regulation of the mTOR/HIF-1α/VEGF Signaling Pathway.
He Y; Lang X; Cheng D; Yang Z
Biol Pharm Bull; 2019 Jun; 42(6):886-891. PubMed ID: 30918132
[TBL] [Abstract][Full Text] [Related]
11. Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells.
Xie SR; Wang Y; Liu CW; Luo K; Cai YQ
Phytother Res; 2012 Aug; 26(8):1133-41. PubMed ID: 22170854
[TBL] [Abstract][Full Text] [Related]
12. HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation.
Yadav A; Vallabu S; Kumar D; Ding G; Charney DN; Chander PN; Singhal PC
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F734-44. PubMed ID: 20015943
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model.
Lang SA; Gaumann A; Koehl GE; Seidel U; Bataille F; Klein D; Ellis LM; Bolder U; Hofstaedter F; Schlitt HJ; Geissler EK; Stoeltzing O
Int J Cancer; 2007 Apr; 120(8):1803-10. PubMed ID: 17230506
[TBL] [Abstract][Full Text] [Related]
14. Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin.
Du W; Gerald D; Perruzzi CA; Rodriguez-Waitkus P; Enayati L; Krishnan B; Edmonds J; Hochman ML; Lev DC; Phung TL
Lab Invest; 2013 Oct; 93(10):1115-27. PubMed ID: 23938603
[TBL] [Abstract][Full Text] [Related]
15. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis.
Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS
J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025
[TBL] [Abstract][Full Text] [Related]
16. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
17. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells.
Kim KM; Heo DR; Lee J; Park JS; Baek MG; Yi JM; Kim H; Bang OS
Chem Biol Interact; 2015 Jan; 225():32-9. PubMed ID: 25446852
[TBL] [Abstract][Full Text] [Related]
18. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation.
Alam H; Maizels ET; Park Y; Ghaey S; Feiger ZJ; Chandel NS; Hunzicker-Dunn M
J Biol Chem; 2004 May; 279(19):19431-40. PubMed ID: 14982927
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells.
Aleffi S; Navari N; Delogu W; Galastri S; Novo E; Rombouts K; Pinzani M; Parola M; Marra F
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G210-9. PubMed ID: 21252047
[TBL] [Abstract][Full Text] [Related]
20. Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy.
Wei J; Jiang H; Gao H; Wang G
Cell Physiol Biochem; 2016; 40(6):1570-1577. PubMed ID: 27997905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
